Featured Articles

  1. The Business Case For Sustainability ― From Industry Resilience To Bottom Line Impact 9/3/2024

    Explore key insights into how sustainability efforts are influencing business outcomes from a survey that collected data from 800 pharma and biopharma executives across 18 countries.

  2. 2024 Global Biopharma Sustainability Review 9/3/2024

    What steps is the biopharma industry taking to enhance sustainability? What challenges does biopharma encounter? And how can the entire industry draw lessons from the companies setting the standard?

  3. Biopharma's Battle With Scope 3 Emissions 9/3/2024

    Given the numerous stakeholders involved throughout a product's lifecycle and the limited direct control companies have, how can biopharma organizations effectively measure and manage Scope 3 emissions?

  4. PUPSIT As Part Of A Contamination Control Strategy (CCS) 8/21/2024

    Learn about the changes introduced in the latest revision to EU GMP Annex 1, and gain insight into the components that should be part of a PUPSIT risk assessment.

  5. When Should Filter Validation Be Performed? 8/21/2024

    Learn about a program that has been developed to facilitate risk mitigation before process-specific filter validation is performed.

  6. The Scalability Of Depth Filters For CHO Cell Culture Clarification 7/19/2024

    Clarification using depth filtration is standard in monoclonal antibody (mAb) manufacturing. Here, we showcase the scalability of Stax™ mAx depth filters, demonstrating their effectiveness.

  7. Is Industry Ready To Take A Bite Out Of Obesity? 7/15/2024

    What are the clinical, economic, and policy considerations for a class of drugs offering a promising treatment for obesity, and how is the industry adapting to meet demand?

  8. New And Upcoming Trends In Immunodiagnostics 7/15/2024

    Explore the latest trends and cutting-edge technologies in immunodiagnostics that are transforming disease detection.

  9. CAR T Set The Pace So All Can Win The Cell Therapy Race 7/15/2024

    Gain insight into the modest origins of cell therapy manufacturing and how this history has paved the way for future advancements from Bill Shingleton, R&D Leader at Cytiva.

  10. When Measuring Filter Performance, Is Performance Absolute? 7/3/2024

    Learn why high-performing filters are inadequate for critical filtration processes and sterilizing-grade filters are necessary to effectively remove undesirable species, including bacteria and viruses.